Australia markets open in 7 hours 44 minutes

Centogene N.V. (CNTG)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
2.6910-0.0290 (-1.07%)
As of 10:08AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close2.7200
Open2.7149
Bid2.6900 x 3000
Ask2.8500 x 1100
Day's range2.6900 - 2.7149
52-week range2.6900 - 11.9500
Volume376
Avg. volume11,527
Market cap72.849M
Beta (5Y monthly)-1.21
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    CENTOGENE’s CentoCloud® Is Now CE-Marked as One of the Only Decentralized SaaS Platforms Compliant With European IVD Regulatory Framework

    CE-marked clinical decision support platform enables laboratories to provide best-in-class diagnostics of genetic diseasesCentoCloud, CENTOGENE’s cloud-based Software as a Service (SaaS) platform, is CE-marked under the In Vitro Diagnostics Directive (98/79/EC)CE-marking is required for all in vitro diagnostic (IVD) devices to be placed in the European Economic Area (EEA) countries, as well as Iceland, Norway, and Liechtenstein, and indicates that the device may be legally commercialized in this

  • GlobeNewswire

    CENTOGENE Contributes to Europe-Wide Efforts to Update Guidelines for Whole Genome Sequencing (WGS) in Rare Disease Diagnostics

    Newly established WGS recommendations published in the European Journal of Human Genetics Collaborative initiative leverages CENTOGENE’s differentiated diagnostic expertise with testing performed in over 650,000 individuals globallyRecommendations provide standardized clinical application guidelines for laboratories to accelerate comprehensive diagnosis and promote better health outcomesWGS increasingly popular for high-quality diagnostics, with the number of CENTOGENE WGS tests increasing doubl

  • GlobeNewswire

    CENTOGENE to Present at the H.C. Wainwright Global Investment Conference

    CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 19, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), the commercial-stage essential biodata life science partner for rare and neurodegenerative diseases, today announced that Company management will present in the virtual track at the H.C. Wainwright Global Investment Conference being held May 23–26, 2022, and invites investors to participate via virtual one-on-one meetings. Please see additional details below: H.C. Wainwright Global I